Ads
related to: jobs for wuxi biologicsLarge Employment Site (>10 Million Unique Visitors Per Month) - TAtech
Search results
Results from the WOW.Com Content Network
WuXi Biologics is a global Contract Research Development and Manufacturing Organization (CRDMO) that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and good ...
Biotech and pharmaceutical companies in the New York metropolitan area represent a significant and growing economic component of the New York metropolitan area, [1] [2] the most populous combined statistical area in the United States [3] and one of the most populous megacities in the world.
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. [1] [2]The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA.
The latest Biosecure Act also adds WuXi Biologics to a list of biotech companies of concern, according to a copy seen by Reuters. The other companies on the list are BGI, MGI, Complete Genomics ...
Shares of WuXi AppTec and WuXi Biologics tumbled on Friday as investor fears grew over the draft legislation targeting the China biotech giants. WuXi AppTec, which provides drug R&D and ...
The company, which is a joint venture between WuXi Biologics and WuXi STA that provides end-to-end contract services covering antibodies and other biologics intermediates, will issue 178.4 million ...
In 2016, WuXi AppTec expanded its presence in the United States by opening a new center of excellence in San Diego, California. [10] This facility was designed to enhance WuXi's capabilities in small molecule screening, discovery biology, and process research and development, while also offering Phase I Good manufacturing practice (GMP) services.
The bill has spurred deep concern among investors, driving a sell-off in the shares of WuXi AppTec when news of its introduction first reached Chinese markets last month. US Senate bill targeting ...